Apolipoprotein A2 (ApoA2)
Second most abundant structural apolipoprotein on HDL particles, existing predominantly as a 17-kDa disulfide-linked homodimer.
Standard vs. Optimal Reference Rangesmg/dL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
25 - 45 mg/dL
General reference distribution across unselected commercial populations.
30 - 40 mg/dL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Modulates hepatic lipase and cholesteryl ester transfer protein (CETP) activity, altering HDL particle size and catabolism.
Differential Diagnosis
Elevated Levels (ApoA2 High)
- •High dietary saturated fat in ApoA2 risk alleles
- •Familial combined hyperlipidemia
Low Levels (ApoA2 Low)
- •ApoA2 deficiency
- •Severe liver failure
- •Hypoalphalipoproteinemia
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for ApoA2
- Targeted organ system imaging or functional dynamic testing related to hdl structural subunit & remodeling
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Apolipoprotein A2 - The New England Journal of Medicine (2021). PMID: 33990124
- [2]ApoA2 Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35222901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Apolipoprotein A2 (ApoA2) into overall healthspan optimization.